Preclinical antimycotic activity of SDZ 89–485: a new orally and topically effective triazole

REFERENCES

• Ackerbauer H., Meingassner J.G., Mieth H. Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis. Mykosen 1984; 28: 244–250
   Google Scholar
• Bechter R., Hamada M., Nakashima T. SDZ 89–485: a systemic antimycotic azole derivative is non-teratogenic in vitro and in vivo. Revista Ibérica de Micologia 1988; 5(Suppl. 1)88–88, [Abstract]
   Google Scholar
• Brammer K.W., Lees L.J. Fluconazole (UK-49,858): a novel oral antifungal in the treatment of fungal skin infections. Results of an open study in 43 patients. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, R.A. Fromtling. J. R. Prous Science Publishers, Barcelona 1987; 157–161, In
   Google Scholar
• Brammer K.W., Tarbit M.H. Single oral dose fluconazole in the treatment of vulvovaginal candidiasis: an interim analysis of a comparative study versus three-day intravaginal clotrimazole tablets. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, R.A. Fromtling. J. R. Prous Science Publishers, Barcelona 1987; 151–156, In
   Google Scholar
• Cauwenbergh G. Prophylaxis of mycotic infections in immunocompromised patients: a review of 27 reports and publications. Drugs under Experimental and Clinical Research 1986; 12: 419–427
   PubMedGoogle Scholar
• Cauwenbergh G., De Donker P. The clinical use of itraconazole in superficial and deep mycoses. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, R.A. Fromtling. J. R. Prous Science Publishers, Barcelona 1987; 113–124, In
   Google Scholar
• Dupont B., Drouhet E. Fluconazole in the management of oropharyngeal candidiasis in a predominantly HIV antibody-positive group of patients. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, R.A. Fromtling. J. R. Prous Science Publishers, Barcelona 1987; 163–168, In
   Google Scholar
• Fierer J., Kirkland T., Finley F. Comparison of fluconazole and SDZ 89–485 for therapy of experimental murine coccidioidomycosis. Antimicrobial Agents and Chemotherapy 1990; 34: 13–16
   PubMed Web of Science ®Google Scholar
• Friedman M. (1) The use of ranks to avoid the assumption of normality implicit in the analysis of variance. Journal of the American Statistic Association 1937; 32: 607–611
   Google Scholar
• Geogopoulos A. Tiefgefrierkonservierung von Pilzen in flüssigem Stickstoff als Grundlage für standardisierte Inokula. Mykosen 1978; 21: 19–23
   PubMedGoogle Scholar
• Grassberger M. SDZ 89–485. Drugs of the Future 1989; 14: 772–774
   Google Scholar
• Graybill J.R. New antifungal agents. European Journal of Clinical Microbiology and Infectious Diseases 1989; 8: 402–412
   PubMed Web of Science ®Google Scholar
• Heeres J., Backx L.J.J., Mostmans J.H., Van Cutsem J. Antimycotic imidazoles, Part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broadspectrum antifungal agent. Journal of Medicinal Chemistry 1979; 22: 1003–1005
   PubMed Web of Science ®Google Scholar
• Heeres J., Backx L.J.J., Van Cutsem J. Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones. Journal of Medicinal Chemistry 1984; 27: 894–900
   PubMed Web of Science ®Google Scholar
• Kan V.L., Bennett J.E. Efficacies of four antifungal agents in experimental murine sporotrichosis. Antimicrobial Agents and Chemotherapy 1988; 32: 1619–1623
   PubMed Web of Science ®Google Scholar
• Male O. Synopsis of mycotic infections in AIDS. Current Problems in Dermatology 1989; 18: 241–249
   PubMedGoogle Scholar
• Marichal P., Gorrens J., Van Cutsem J., Vanden Bossche H. Culture media for the study of the effects of azole derivatives on germ tube formation and hyphal growth of C. albicans. Mykosen 1986; 29: 76–81
   PubMedGoogle Scholar
• Marriott M.S., Richardson K. The discovery and mode of action of fluconazole. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, R.A. Fromtling. J. R. Prous Science Publishers, Barcelona 1987; 81–92, In
   Google Scholar
• Meunier F., Gerain J., Snoek R., Libotte F., Lambert C., Ceuppens A.M. Fluconazole therapy of oropharyngeal candidiasis in cancer patients. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, R.A. Fromtling. J. R. Prous Science Publishers, Barcelona 1987; 169–174, In
   Google Scholar
• Meunier-Carpentier F., Kiehn T.E., Armstrong D. Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. American Journal of Medicine 1981; 71: 363–370
   PubMed Web of Science ®Google Scholar
• Odds F.C. Problems in the laboratory assessment of antifungal activity. Postgraduate Medical Journal 1979; 55: 677–680
   PubMed Web of Science ®Google Scholar
• Perfect J.R. Antifungal therapy 1989. Current Opinion in Infectious Diseases 1989; 2: 568–571
   Web of Science ®Google Scholar
• Petranyi G., Leitner I., Mieth H. The hair-root invasion test, a semi-quantitative method for experimental evaluation of antimycotics on guinea pigs. Sabouraudia 1982; 20: 101–108
   PubMedGoogle Scholar
• Petranyi G., Meingassner J.G., Mieth H. Activity of terbinafine in experimental fungal infections of laboratory animals. Antimicrobial Agents and Chemotherapy 1987; 31: 1558–1561
   PubMed Web of Science ®Google Scholar
• Polak A., Schaffner A. A new experimental model of localized candidosis for the study of antifungal chemotherapy. Mycoses 1988; 32: 398–404
   Web of Science ®Google Scholar
• Schaude M., Ackerbauer H., Mieth H. Inhibitory effect of antifungal agents on germ tube formation in Candida albicans. Mykosen 1987; 30(6)281–287
   PubMedGoogle Scholar
• Schaude M., Meingassner J.G. A diffusion chamber technique for testing of antifungal drugs against Sporothrix schenckii in vivo. Journal of Medical and Veterinary Mycology 1986; 24: 297–304
   PubMedGoogle Scholar
• Schaude M., Mieth H. In vitro activity of SDZ 89–485, a new orally-active triazole antifungal. Revista Ibérica de Micologia 1988; 5(Suppl. 1)88–88, [Abstract]
   Google Scholar
• Schuster I., Meingassner J.G. SDZ 89–485: a study of interactions with mammalian cytochromes P-450 in vitro and in vivo. Revista Ibérica de Micologia 1988; 5(Suppl. 1)89–89, [Abstract]
   Google Scholar
• Spencer P.M., Jackson G.G. Fungal and mycobacterial infections in patients infected with the human immunodeficiency virus. Journal of Antimicrobial Chemotherapy 1989; 23(Suppl. A)107–125
   PubMed Web of Science ®Google Scholar
• Stevens D.A. Problems in antifungal chemotherapy. Infection 1987; 15: 87–92
   PubMed Web of Science ®Google Scholar